Basic Information
Akura Medical, a privately held portfolio company of Shifamed LLC, is a medical technology company focused on addressing venous thromboembolism (VTE). Our flagship product, the Katana™ Thrombectomy System, is poised to redefine the treatment standard for pulmonary embolism (PE) by removing various types of clots more efficiently. The Katana Thrombectomy System embodies our mission to reshape the VTE care landscape and profoundly impact the lives of patients worldwide.
Akura Medical, Inc.
California,United States of America
15~50 people
January 01, 2019
info@akuramedical.com

